Neurol India Home 
 

LETTER TO EDITOR
Year : 2009  |  Volume : 57  |  Issue : 6  |  Page : 815--817

Intracerebral hemorrhages in Vogt-Koyanagi-Harada disease

Neeraj N Baheti1, Ajith Cherian1, Mahesh Kate1, Syam Krishnan1, Bejoy Thomas2,  
1 Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India
2 Department of Imaging Sciences and Interventional Radiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India

Correspondence Address:
Ajith Cherian
Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala
India




How to cite this article:
Baheti NN, Cherian A, Kate M, Krishnan S, Thomas B. Intracerebral hemorrhages in Vogt-Koyanagi-Harada disease.Neurol India 2009;57:815-817


How to cite this URL:
Baheti NN, Cherian A, Kate M, Krishnan S, Thomas B. Intracerebral hemorrhages in Vogt-Koyanagi-Harada disease. Neurol India [serial online] 2009 [cited 2019 Dec 7 ];57:815-817
Available from: http://www.neurologyindia.com/text.asp?2009/57/6/815/59491


Full Text

Sir,

Vogt-Koyanagi-Harada (VKH) disease is a multisystem disorder characterized by granulomatous panuveitis with exudative retinal detachments often associated with neurologic, acoustic and cutaneous manifestations. [1] The neurological features of VKH disease include headache, meningismus, cranial nerve palsies, hemiparesis, transverse myelitis and ciliary ganglionitis. [1] Intracerebral hemorrhage has not been described earlier. We describe a male patient with VKH disease who presented with ataxia secondary to intracerebral hemorrhage.

A 26-year-old gentleman presented with acute onset headache, vomiting, imbalance while walking and incoordination of the upper limbs. There was no history of weakness, sensory impairment or any cranial nerve deficit. He gave a history of recurrent nontraumatic uveitis involving the right eye for the last 2 years. His first evaluation 2 weeks into the illness showed reduced visual acuity (20/200) in the right eye, the left eye being normal (20/20). The anterior chamber showed flare with hazy media. Evaluation for sarcoid, tuberculosis, syphilis and vasculitis was negative. He was initiated on steroids, with total improvement over 4 weeks. He later discontinued steroids due to weight gain. One month after stopping steroids, he developed redness of the same eye with visual deterioration. Evaluation showed exudative retinal detachment. Eventually, he developed complicated cataract and prepthisical changes. He also had two episodes of low-grade fever with headache and terminal neck stiffness without altered sensorium or focal deficits and was treated symptomatically. Examination at the present admission revealed patches of vitiligo on his back. Visual acuity was 20/20 in the left eye and no perception of light in the right eye. Ophthalmic evaluation showed phthisis bulbi and complicated cataract in the right eye [Figure 1]. The left eye showed optic disc edema, tortuous veins and choroidal folds [Figure 2]. Neurological examination showed gaze-evoked nystagmus and bilateral upper and lower limb incoordination with gait ataxia.

Cerebrospinal fluid (CSF) showed pleocytosis 90 cells/ mm 3 (100% lymphocytes) with normal sugar (CSF: Plasma glucose 0.65) and mildly elevated protein (64 mg/dl). Audiometry showed bilateral mild sensorineural hearing loss. Ultrasonography B-mode scan of the right eye showed cone-shaped retinal detachment with subretinal hemorrhage. Biopsy from the eye was withheld because of risk of sympathetic ophthalmitis. Magnetic resonance imaging (MRI) of the brain [Figure 3] showed bilateral cerebellar, vermian and basifrontal bleed with mild leptomeningeal enhancement on postcontrast T1-weighted images. Four-vessel digital subtraction angiogram was normal. He responded excellently to a course of intravenous steroids and was continued on oral steroids. On discharge, he could walk normally and was asymptomatic at the 3-month follow-up.

VKH syndrome is a rare systemic disease involving melanocyte-containing organs. VKH occurs more commonly in patients with a genetic predisposition to the disease, including Asian, Middle Eastern, Hispanic and Native American populations. [1] The highest prevalence is in Japan, where VKH disease represents 6.8-9.2% of all patients with uveitis. [1] VKH is related to an aberrant T cell-mediated immune response directed against self-antigens found on melanocytes. Yamaki and coworkers have shown that the tyrosinase-related proteins, TRP1 and TRP2, can induce disease in Lewis rats that is similar to VKH disease in humans. [2] Thus, any organ containing melanocytes or tyrosinase can be affected in VKH disease. The International Committee on Nomenclature has established revised criteria for the diagnosis of VKH disease. [3] Our patient satisfied the complete diagnostic criteria for VKH. A literature search reveals infrequent case reports of neurological complications. An early case report of VKH with vestibular and cerebellar ataxia and another with multiple cranial nerve palsies has been reported, which improved with steroid therapy, but imaging was not performed. [4] Osaki et al. have reported the case of a 57-year-old Japanese male with VKH who presented with truncal ataxia in whom MRI revealed cerebellar vermian contrast enhancement. [5]

Our patient had multiple areas of parenchymal bleed confirmed by SWI and leptomeningeal enhancement on postcontrast MRI. Intracerebral bleed in our case might have resulted from T cell-mediated cytotoxicity along with humoral autoimmune response directed against tyrosinase-related proteins found in the neurons. Immune-mediated damage breaks the blood brain barrier, which manifested as leptomeningeal enhancement. The fact that he made excellent recovery to immunomodulatory therapy highlights the need for prompt recognition and management to avoid morbidity.

References

1Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi- Harada syndrome. Surv Ophthalmol 1995;39:265-92.
2Yamaki K, Gocho K, Hayakawa K, Kondo I, Sakuragi S. Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease. J Immunol 2000;165:7323-9.
3Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: Report of an international committee on nomenclature. Am J Ophthalmol 2001;131:647-52.
4Hiraki Y, Kuwasaki N, Shoji H, Kaji M, Kuboshiro T. Each one case of Vogt-Koyanagi-Harada disease with vestibular and cerebellar ataxia, and multiple cranial nerve palsies. Rinsho Shinkeigaku 1989;29:54-8.
5Osaki Y, Matsubayashi K, Doi Y, Ozawa T. Vogt-Koyanagi-Harada disease with cerebellar lesions demonstrated on MRI: A case report. Rinsho Shinkeigaku 1995;35:1160-2.